11 ways to support cancer patients and survivors this holiday...
Holiday celebrations look a lot different this year because of the coronavirus (COVID-19) pandemic. It’s a difficult time for...
Multiple myeloma: When to treat and when to wait
Multiple myeloma is a cancer that develops in a type of white blood cell called plasma cells. Normally, these cells help us make...
How molecular testing and targeted therapy are changing...
B-cell lymphoma isn’t one disease. There are about 63 subtypes, with diffuse large B-cell lymphoma (DLBCL) being the most common. A...
Clinical trials glossary: 12 terms to know
New and better cancer treatments are discovered through clinical trials. By joining one, patients get access to the most cutting-edge...
Monoclonal antibodies and cancer treatment: What to know
Last updated Jan. 11, 2022.
First emerging almost three decades ago, monoclonal antibodies are changing the way doctors treat cancer...
Predicting and preventing CAR T cell therapy side effects...
CAR T cell therapy has changed the way aggressive B-cell lymphoma is treated. Previously, when patients had a second recurrence after...